Cerusendo Microcatheter
Cerus Endovascular
FDA Clearance Information
The Cerusendo Microcatheter was cleared by the FDA through the 510k pathway on July 20, 2019. It is manufactured by Cerus Endovascular and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Percutaneous intravascular access and navigation during endovascular procedures.
- Delivery of therapeutic agents or devices within the vascular system when used with compatible equipment.
- Use in accordance with the specific device labeling, including its stated size, compatibility, and intended vascular application.
Clinical Applications
- Selective catheterization of blood vessels during image-guided endovascular procedures.
- Delivery of compatible embolic materials or other therapeutic agents.
- Delivery of compatible interventional devices through a catheter system.
- Navigation through complex or tortuous vascular anatomy when clinically appropriate.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The available sizes, lengths, distal-tip configuration, and other specifications should be checked in the current manufacturer’s instructions for use.
- Use requires compatible guidewires, introducers, diagnostic catheters, and therapeutic devices; compatibility should be confirmed before the procedure.
- The catheter is generally handled under fluoroscopic or other appropriate imaging guidance by trained personnel.
- MRI safety depends on the specific device configuration and labeling. Confirm MR Safe, MR Conditional, or MR Unsafe status before MRI.
- Potential complications are those associated with intravascular catheterization, including vessel injury, dissection, perforation, thrombosis, embolization, bleeding, infection, and contrast-related reactions.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for Cerusendo Microcatheter?
The Cerusendo Microcatheter is indicated for use in endovascular procedures requiring navigation through complex vascular anatomies.
What outcomes have been reported in clinical studies?
Studies report enhanced procedural success and accurate device placement in complex vascular interventions.
What complications have been reported?
Complications include microcatheter entrapment and procedural challenges, particularly in highly angulated lesions.